BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23317949)

  • 1. Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis.
    Lee JS; Park DA; Hong Y; Jo KW; Lee SW; Huh JW; Oh YM; Lee SD
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):153-62. PubMed ID: 23317949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010010. PubMed ID: 28626902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic antibiotic therapy for chronic bronchitis.
    Staykova T; Black PN; Chacko EE; Poole P
    Cochrane Database Syst Rev; 2003; (1):CD004105. PubMed ID: 12535510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
    Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
    Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.
    El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM
    Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
    Wang Y; Zijp TR; Bahar MA; Kocks JWH; Wilffert B; Hak E
    J Antimicrob Chemother; 2018 Dec; 73(12):3231-3243. PubMed ID: 30189002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.
    Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
    Pulm Pharmacol Ther; 2018 Feb; 48():185-194. PubMed ID: 29233650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.
    Puhan MA; Vollenweider D; Latshang T; Steurer J; Steurer-Stey C
    Respir Res; 2007 Apr; 8(1):30. PubMed ID: 17407610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease.
    Solèr M; Mütterlein R; Cozma G;
    Respiration; 2007; 74(1):26-32. PubMed ID: 16772707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations?
    Bont J; Hak E; Birkhoff CE; Hoes AW; Verheij TJ
    Fam Pract; 2007 Sep; 24(4):317-22. PubMed ID: 17602175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does antibiotic treatment duration affect the outcomes of exacerbations of asthma and COPD? A systematic review.
    Stolbrink M; Amiry J; Blakey JD
    Chron Respir Dis; 2018 Aug; 15(3):225-240. PubMed ID: 29232988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Miravitlles M; Llor C; Naberan K; Cots JM; Molina J;
    Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No more equivalence trials for antibiotics in exacerbations of COPD, please.
    Miravitlles M; Torres A
    Chest; 2004 Mar; 125(3):811-3. PubMed ID: 15006934
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic antibiotic therapy in chronic obstructive pulmonary disease.
    Herath SC; Poole P
    JAMA; 2014 Jun; 311(21):2225-6. PubMed ID: 24893090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.